BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behzadifar M, Gorji HA, Bragazzi NL. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis. Arch Virol 2018;163:1131-40. [DOI: 10.1007/s00705-018-3767-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Behzadifar M, Azari S, Gorji HA, Martini M, Bragazzi NL. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges. J Prev Med Hyg 2020;61:E109-18. [PMID: 32490276 DOI: 10.15167/2421-4248/jpmh2020.61.1.1438] [Reference Citation Analysis]
2 Behzadifar M, Gorji HA, Rezapour A, Bragazzi NL. Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia. Journal of Virus Eradication 2019;5:116-21. [DOI: 10.1016/s2055-6640(20)30053-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Akhtar S, Nasir JA, Hinde A. The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis. BMC Public Health 2020;20:587. [PMID: 32349737 DOI: 10.1186/s12889-020-8414-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nasimzadeh S, Azaran A, Jalilian S, Makvandi M, Seyedian SS, Keikhaei B, Mehr FJ. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran. Arch Virol 2021;166:2703-10. [PMID: 34275067 DOI: 10.1007/s00705-021-05126-7] [Reference Citation Analysis]
5 Behzadifar M, Gorji HA, Rezapour A, Rezvanian A, Bragazzi NL, Vatankhah S. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis. Health Res Policy Syst 2019;17:42. [PMID: 30992014 DOI: 10.1186/s12961-019-0442-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ahmed S, Ayub M, Naeem M, Nazir FH, Hussain A, Ghilzai D, Magnius LO, Sajjad A, Norder H. Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains. Am J Trop Med Hyg 2021:tpmd200740. [PMID: 33534738 DOI: 10.4269/ajtmh.20-0740] [Reference Citation Analysis]
7 Behzadifar M, Behzadifar M, Bragazzi NL. A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran. BMC Public Health 2020;20:62. [PMID: 31937278 DOI: 10.1186/s12889-020-8175-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mirzaei G, Shamsasenjan K, Jafari B, Bagherizadeh Y, Sadafzadeh A, Bannazadeh-Baghi H, Sadeghi-Deylamdeh Z, Jafari-Sales A. Prevalence of HBV and HCV infection in beta-thalassemia major patients of Tabriz city, Iran. New Microbes New Infect 2021;43:100912. [PMID: 34401191 DOI: 10.1016/j.nmni.2021.100912] [Reference Citation Analysis]
9 Ayadi A, Nafari AH, Irani S, Mohebbi E, Mohebbi F, Sakhaee F, Vaziri F, Siadat SD, Fateh A. Occult hepatitis C virus infection in patients with beta-thalassemia major: Is it a neglected and unexplained phenomenon? J Cell Biochem. 2019;120:11908-11914. [PMID: 30775813 DOI: 10.1002/jcb.28472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hadipour Dehshal M, Tabrizi Namini M, Hantoushzadeh R, Yousefi Darestani S. β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease. Hemoglobin 2019;43:166-73. [DOI: 10.1080/03630269.2019.1628774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]